Should the FDA work closer with its European counterpart?
Should U.S. drug companies benefit from European testing results? Avik Roy joins Jim Blasingame to compare the U.S. and European drug testing systems to bring new drugs to the market, plus the added costs of litigation.
Category:
Government, Politics, Trade Groups and Think Tanks
More interviews with Avik Roy »See all
Avik Roy joins Jim Blasingame to discuss why United Healthcare is leaving Obamacare exchanges and whether the law is collapsing in front of our eyes.
Avik Roy joins Jim Blasingame to compare and contrast conservatism and nationalism and which direction Trump will lean if he becomes president.
Avik Roy joins Jim Blasingame to reveal how the Donald Trump candidacy has turned the Republican Party from a conservative to a nationalist party.
Avik Roy joins Jim Blasingame to report on the current presidential campaigning and why there isn’t more debate on how to reform health care, and a post-Obamacare environment.
Avik Roy joins Jim Blasingame to report on the condition of Obamacare and the impact it has had on the marketplace and the economy, including how few people have really benefited from it.
